Emory University a
line a aaa line
  a November 11, 2013 a a

Research Extras

Read about Emory's latest member of the Institute of Medicine, Carlos del Rio.

Learn more about how Emory's external research funding topped $500 million.

The partnership between Emory and Georgia Tech is a blueprint for collaboration between a public and private university. Read how joint programs continue to extend beyond their biomedical engineering roots.

The Queensland Emory Research Alliance has chosen two difficult cancer challenges for its first major research projects.

A new NIH-funded training program will help expand career choices for science graduate students.

The Center for Behavioral Health Policy Studies at Rollins School of Public Health aims to improve the lives of people with mental and substance use disorders through research, education, and service.


a a

eye-tracking technology
Infants normally show increasing attention to eyes


Eye Tracking Shows Declining Attention in Infants Later Diagnosed with Autism
Researchers used eye-tracking technology to follow babies from birth to age 3 and found infants later diagnosed with autism showed declining attention to the eyes of other people from 2 months onward. In the earliest months, attention to others' eyes was not entirely absent, so early interventions might have an impact. Infants whose eye contact declined most rapidly were most disabled later in life. Read more...


a a

Donor egg in-vitro fertilization


Donor Egg IVF Increases, Along with Better Outcomes
The number of donor egg in-vitro fertilization cycles increased over a 10-year period along with an increase in single-embryo transfers and cycles that involved frozen embryos. Data from 443 clinics found that good outcomes (a single live-born infant delivered at 37 weeks or later weighing at least 5.5 lbs.) increased from 18.5 to 24.4 percent with improved technology and better access to donor eggs and better freezing capabilities. Read more...

a a

Donor egg in-vitro fertilizationAlginate capsules around mesenchymal stem cells


Encapsulated Stem Cells Could Help Regenerate Diseased Hearts
Cardiologists have a new way to package stem cells for regenerative therapy for heart disease, using a capsule made of the gel-like substance alginate. The capsules allow cells to stay alive and release their healing factors over time. Packaged stem cells from the bone marrow, used to treat the hearts of rats after heart attack, showed increased heart function, reduced scar size and more growth of new blood vessels compared with unpackaged cells. Read more...

a a
Testing a therapy for ALS
Neurons functioning normally

Phase II of ALS Stem Cell Trial Under Way
A Phase II clinical trial at Emory and the University of Michigan is testing a therapy for ALS (Lou Gehrig's disease) using human neural stem cells implanted into the spinal cord. The dose escalation and safety trial will treat up to 15 patients in five dosing groups. An earlier Phase I trial assessed the safety of the implants in 18 patients. The study is funded by a grant from the NIH and by the company Neuralstem, Inc., which provides the cells. Read more...

a a

Professor Jacques Galipeau
Jacques Galipeau, MD


Pushing the Immune System into Overdrive
Researchers have found a way to energize the immune system by combining two kinds of cytokines (molecules that signal immune responses). The engineered molecules, called GIFT fusokines, dock into receptors on immune cells and activate them. Clustering these cells leads to a hyperactive immune response that could be used to boost the power of vaccines, restore elderly immune systems, or help fight cancer or infectious diseases. Read more...

Woodruff Health Sciences Center
Link to the Current Issue More Research News Archives Contact Us Holly Korshun David Stephens